DNA-repair gene variants are associated with glioblastoma survival

Acta Oncologica

Volumn 51, Issue 3, 2012, Pages 325-332

  Wibom, Carl ^a,b   Sjöström, Sara ^a   Henriksson, Roger ^a   Brännström, Thomas ^b   Broholm, Helle ^c   Rydén, Patrik ^b   Johansen, Christoffer ^d   Collatz Laier, Helle ^e   Hepworth, Sara ^f   McKinney, Patricia A ^f   Bethke, Lara ^g   Houlston, Richard S ^g   Andersson, Ulrika ^a   Melin, Beatrice S ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Mental Health Center Glostrup   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e SLAGELSE HOSPITAL   (Denmark)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NUCLEIC ACID BINDING PROTEIN; PROTEIN MSH2; PROTEIN RAD51L1; PROTEIN RECQL4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERM LINE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; TREATMENT RESPONSE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; DENMARK; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOBLASTOMA; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECQ HELICASES; SURVIVAL RATE; SWEDEN; YOUNG ADULT;

EID: 84859753765     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.616284     Document Type: Article

References (28)

1. Jeggo P, Lavin MF. Cellular radiosensitivity: How much better do we understand it? Int. J. Radiat Biol 2009;85: 1061-81.
2. Ohnishi T, Taki T, Hiraga S, Arita N, Morita T. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem. Biophys. Res. Comm. 1998;245:319-24.
3. Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C, et al. The INTERPHONE study: Design, epidemiological methods, and description of the study population. Eur. J. Epidemiol. 2007;22:647-64.
4. Hepworth SJ, Schoemaker MJ, Muir KR, Swerdlow AJ, Van Tongeren MJ, McKinney PA. Mobile phone use and risk of glioma in adults: Case-control study. BMJ 2006;332: 883-7.
5. Andersson U, Osterman P, Sjostrom S, Johansen C, Henriksson R, Brannstrom T, et al. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int. J. Cancer 2009;125:968-72.
6. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifi es fi ve susceptibility loci for glioma. Nat. Genet. 2009;41:899-904.
7. Sjös tröm S, Andersson U, Liu Y, Brän nström T, Broholm H, Johansen C, et al. Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro-oncology Epub 2010 Mar 2.
8. Andersson U, Schwartzbaum J, Wiklund F, Sjostrom S, Liu Y, Tsavachidis S, et al. A compre hensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta. Oncol. Epub 2010 May 7.
9. Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC, et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum. Mol. Genet. 2008;17:800-5.
10. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, et al. The UCSC Genome Browser Database. Nucleic Acids Res 2003;31:51-4.
11. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
12. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat. Res. 2005;577:275-83.
13. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 2004;74: 106-20.
14. The International HapMap Project. Nature 2003;426: 789-96.
15. Conde L, Vaquerizas JM, Dopazo H, Arbiza L, Reumers J, Rousseau F, et al. PupaSuite: Finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res. 2006;34(Web Server issue):W621 - 5.
16. Lystig TC. Adjusted P values for genome-wide scans. Genetics 2003;164:1683-7.
17. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
18. Petkovic M, Dietschy T, Freire R, Jiao R, Stagljar I. The human Rothmund-Thomson syndrome gene product, RECQL4, localizes to distinct nuclear foci that coincide with proteins involved in the maintenance of genome stability. J. Cell Sci. 2005;118(Pt 18):4261-9.
19. Kitao S, Lindor NM, Shiratori M, Furuichi Y, Shimamoto A. Rothmund-thomson syndrome responsible gene, RECQL4: Genomic structure and products. Genomics 1999;61:268-76.
20. Fishel R, Ewel A, Lescoe MK. Purifi ed human MSH2 protein binds to DNA containing mismatched nucleotides. Cancer Res. 1994;54:5539-42.
21. Stark AM, Witzel P, Strege RJ, Hugo HH, Mehdorn HM. p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme. J Neurol Neurosurg Psychiatry 2003;74:779 - 83.
22. Kawabata M, Kawabata T, Nishibori M. Role of recA/RAD51 family proteins in mammals. Acta Medica Okayama 2005;59:1-9.
23. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifi es two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet. 2009;41: 579-84.
24. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 2009;41:905-8.
25. Li D, Frazier M, Evans DB, Hess KR, Crane CH, Jiao L, et al. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 2006;24:1720-8.
26. Rodero M, Marie Y, Coudert M, Blondet E, Mokhrari K, Rousseau A, et al. Polymorphism in the microglial cellmobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol 2008;26:5957-64.
27. Scheurer ME, Amirian E, Cao Y, Gilbert MR, Aldape KD, Kornguth DG, et al. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin. Cancer Res. 2008;14:6640-6.
28. Carpentier C, Lejeune J, Gros F, Everhard S, Marie Y, Kaloshi G, et al. Association of telomerase gene hTERT polymorphism and malignant gliomas. J. Neuro-oncol. 2007;84:249-53.